Complex ANDAs To Be Allowed Pre-Submission Product Meetings

The meeting process for ANDAs targeting complex products that FDA will implement during GDUFA II is intended to help agency reviewers as much as sponsors.

Sponsors will have opportunities to gain advice from agency scientists and others on their standards prior to submitting an application